5 Things to Read Instead OfIt’s finally the end of the week, one which for most of us consisted of a heck of a lot of gene editing chat. This came after a team of researchers announced that they successfully corrected a defective gene that causes inherited diseases in an embryo. Of course, this is an incredibly exciting step forward in the field, but one that brings with it a whole lot of ethical debate. Whilst it is all very interesting, we have given you a little breather by providing five stories to read instead of…

Biological Teleporter Could Seed Life Through Galaxy 

Starting with just a digital file, scientists manufactured the common flu virus. The device, called a “digital-to-biological converter” is a conglomeration of small machines and lab robots, linked to each other to form one big machine. But this one can do something unprecedented: it can use transmitted digital code to print viruses. 

IVF Babies Grow Up Heavier and May Have Higher Risk of Obesity 

Since the first “test tube baby” arrived 39 years ago, an estimated 6.5 million children have been born thanks to IVF and similar techniques. But we are only just starting to learn about the long-term health of people conceived using assisted reproduction techniques, who may have a higher risk of obesity later in life. 

Three Large Companies Put Aside Their Differences to Come Together for Patients

In June the FDA approved for the first time an NGS panel with multiple genes for multiple drugs that treat non-small cell lung cancer. How did Thermo Fisher decide on this panel, and what possible future uses to do they see? Listen to this podcast with three of the industry’s leaders from Thermo Fisher, Pfizer and Novartis, as it uncovers the work behind a major milestone for precision oncology. 

We May Finally Be Able to Slow Parkinson’s With a Diabetes Drug

A diabetes drug can slow the progress of Parkinson’s disease, and seems to target the underlying cause of the condition, not just its symptoms. The finding adds weight to the theory that the two conditions work in a similar way. 

Artist Creates Portraits Using Chelsea Manning’s DNA 

By algorithmically analysing DNA extracted from Manning and using it to create 30 portraits of what someone with that genomic data might look like, Dewey-Hagborg has created a trenchant, if somewhat cerebral, commentary on not only the malleability of DNA data – the many ways it can be interpreted, and the inherent determinism of those interpretations – but also identity.